在克罗恩病中粘膜DNA甲基组的改变:手术和非手术组
Saeed Ahmad1,2, Mia Sands1,2, Eugene Greenberg3
1Biomedical Research Center, Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL, United States.
Frontiers in genetics
|December 4, 2023
概括
DNA甲基化模式的表观遗传变化与克罗恩病 (CD) 的进展有关. 在手术和非手术CD患者中,独特的DNA甲基化特征可以作为疾病分期的生物标志物.
科学领域:
- 胃肠病学 胃肠病学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 基因组学就是基因组学.
背景情况:
- 克罗恩病 (CD) 是一种复杂的慢性疾病,具有多因素的病因.
- 全基因组关联研究 (GWAS) 识别了遗传变异,但它们解释了有限的疾病易感性,表明表观遗传学的作用.
- 表观遗传修饰,特别是DNA甲基化,对于将环境因素与CD的遗传倾向联系起来至关重要.
研究的目的:
- 调查与克罗恩病进展有关的DNA甲基组进化.
- 与健康对照组相比,在非手术和手术CD患者组中识别差异性DNA甲基化模式.
- 探索DNA甲基化特征的潜力,以确定疾病的阶段.
主要方法:
- 减少表示双硫酸盐测序 (RRBS) 用于分析DNA甲基化.
- 使用来自非手术和手术CD患者以及健康对照者的粘膜组织.
- 进行了差异甲基化分析,考虑了单核酸多态 (SNP).
主要成果:
- 与健康组织相比,在非手术 (1,671个位点) 和手术 (3,334个位点) CD 患者组中观察到明显的 DNA 甲基化特征.
- 在手术和非手术组之间,只有206个不同的甲基化位点重叠.
- 在GWAS涉及的基因中确定了差异甲基化,功能丰富分析突出了参与CD病变的关键途径.
结论:
- 特定的DNA甲基化模式是非手术和手术CD患者的粘膜组织的特征.
- 这些模式表明甲基组的进化与疾病进展相关.
- 已识别的DNA甲基化特征可以作为生物标志物来区分克罗恩病的不同阶段.
相关概念视频
01:21Inflammatory Bowel Disease V: Surgical Management
148
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
148
01:30Inflammatory Bowel Disease II: Crohn's Disease
255
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
255
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168